Multi-Omics Integration
Whole Genome Sequencing, Proteomics, and Epigenomics layers combined for deep biological context.
A unified computational ecosystem that bridges the gap between target identification and clinical-grade drug design. PanAum transforms static targets into dynamic, population-characterized therapeutic assets — multi-omics, network biology, pharmacogenomics, and generative chemistry in one automated workflow.
Whole Genome Sequencing, Proteomics, and Epigenomics layers combined for deep biological context.
Five advanced metrics (Degree, Betweenness, Closeness, Eigenvector, and PageRank) for rigorous target scoring.
Population-level variant profiling built into every stage, from target selection through to the final clinical report.
Specialized workflows for Small Molecules, Antibodies, PROTACs, and Novel Target classes.
Six automated stages from evidence input to executive-ready reporting, with full scientific provenance throughout.